The January 10, 2017, article by Nogova et al, entitled “Evaluation of BGJ398, a Fibroblast Growth Factor Receptor 1-3 Kinase Inhibitor, in Patients With Advanced Solid Tumors Harboring Genetic Alterations in Fibroblast Growth Factor Receptors: Results of a Global Phase I, Dose-Escalation and Dose-Expansion Study” (J Clin Oncol 35:157-165, 2017), was published with an omission.
In the Affiliations section, START Madrid should have been listed as an affiliation of Manuel Hidalgo.
The online version has been corrected in departure from the print. The authors apologize for the error.